|
G |
Adra1a |
adrenoceptor alpha 1A |
increases expression |
EXP |
Tramadol results in increased expression of ADRA1A protein |
CTD |
PMID:15464068 |
|
NCBI chr15:45,005,648...45,111,416
Ensembl chr15:40,832,534...40,927,500
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions increases expression |
EXP |
Vitamin E inhibits the reaction [Tramadol results in increased expression of ALPL protein] |
CTD |
PMID:31618080 |
|
NCBI chr 5:155,234,770...155,289,785
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
EXP |
Tramadol results in increased expression of BAX protein |
CTD |
PMID:25550769 |
|
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bche |
butyrylcholinesterase |
decreases activity |
EXP |
Tramadol results in decreased activity of BCHE protein |
CTD |
PMID:28689766 |
|
NCBI chr 2:160,607,289...160,699,760
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Casp3 |
caspase 3 |
affects activity decreases activity multiple interactions increases expression |
ISO EXP |
Tramadol affects the activity of CASP3 protein Tramadol results in decreased activity of CASP3 protein Vitamin E inhibits the reaction [Tramadol results in increased expression of CASP3 protein] |
CTD |
PMID:27317026 PMID:28499616 PMID:31618080 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
decreases expression multiple interactions |
EXP |
Tramadol results in decreased expression of CAT mRNA; Tramadol results in decreased expression of CAT protein Tramadol deficiency inhibits the reaction [Tramadol results in increased expression of CAT mRNA] |
CTD |
PMID:25550769 PMID:31618080 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ckb |
creatine kinase B |
decreases expression multiple interactions |
ISO EXP |
Tramadol results in decreased expression of CKB mRNA Ethanol promotes the reaction [Tramadol results in increased expression of [CKM protein binds to CKB protein]]; Tramadol promotes the reaction [Ethanol results in increased expression of [CKM protein binds to CKB protein]]; Tramadol results in increased expression of [CKM protein binds to CKB protein] |
CTD |
PMID:27317026 PMID:33645892 |
|
NCBI chr 6:136,550,583...136,553,464
Ensembl chr 6:130,729,423...130,732,315
|
|
G |
Ckm |
creatine kinase, M-type |
multiple interactions |
EXP |
Ethanol promotes the reaction [Tramadol results in increased expression of [CKM protein binds to CKB protein]]; Tramadol promotes the reaction [Ethanol results in increased expression of [CKM protein binds to CKB protein]]; Tramadol results in increased expression of [CKM protein binds to CKB protein] |
CTD |
PMID:33645892 |
|
NCBI chr 1:88,189,382...88,199,717
Ensembl chr 1:79,061,456...79,071,720
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
increases phosphorylation |
EXP |
tramadol increases phosphorylation of Creb1 protein in Prefrontal Cortex and nucleus accumbens |
RGD |
PMID:30632799 |
RGD:401901180 |
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases activity |
ISO |
Tramadol results in decreased activity of CYP17A1 protein |
CTD |
PMID:29100959 |
|
NCBI chr 1:255,476,861...255,484,547
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
increases response to substance affects metabolic processing decreases response to substance affects response to substance multiple interactions decreases methylation increases metabolic processing affects methylation |
ISO |
CYP2D6 gene mutant form results in increased susceptibility to Tramadol CYP2D6 gene mutant form affects the metabolism of Tramadol; CYP2D6 gene polymorphism affects the metabolism of Tramadol CYP2D6 gene polymorphism results in decreased susceptibility to Tramadol CYP2D6 affects the susceptibility to Tramadol; CYP2D6 gene polymorphism affects the susceptibility to Tramadol; CYP2D6 protein affects the susceptibility to Tramadol [CYP2D6 protein results in increased metabolism of and results in increased activity of Tramadol] which results in increased chemical synthesis of O-demethyltramadol; CYP2D6 gene polymorphism affects the metabolism of and affects the susceptibility to Tramadol; CYP2D6 protein results in increased metabolism of and results in increased activity of Tramadol CYP2D6 protein results in decreased methylation of Tramadol CYP2D6 gene mutant form results in increased metabolism of Tramadol; CYP2D6 protein results in increased metabolism of Tramadol CYP2D6 protein affects the methylation of Tramadol |
CTD |
PMID:12191703 PMID:12893130 PMID:14624403 PMID:16497087 PMID:16960721 PMID:17361124 PMID:17470523 PMID:17570739 PMID:18204346 PMID:18520597 PMID:18713907 PMID:29555325 PMID:31173123 More...
|
|
NCBI chr 7:115,762,662...115,771,832
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Des |
desmin |
multiple interactions |
EXP |
Tramadol promotes the reaction [Ethanol results in increased expression of DES protein] |
CTD |
PMID:33645892 |
|
NCBI chr 9:84,299,626...84,307,344
Ensembl chr 9:76,850,982...76,858,699
|
|
G |
Drd2 |
dopamine receptor D2 |
increases expression |
EXP |
Tramadol results in increased expression of DRD2 protein |
CTD |
PMID:15464068 |
|
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:49,708,927...49,772,875
|
|
G |
Drd3 |
dopamine receptor D3 |
increases expression |
EXP |
Tramadol results in increased expression of DRD3 protein |
CTD |
PMID:15464068 |
|
NCBI chr11:70,385,586...70,437,793
Ensembl chr11:56,879,689...56,940,596
|
|
G |
Fosb |
FosB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
Tramadol increases expression of Fosb protein in Prefrontal Cortex and nucleus accumbens |
RGD |
PMID:30632799 |
RGD:401901180 |
NCBI chr 1:88,082,324...88,089,506
Ensembl chr 1:78,954,115...78,961,465
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
EXP |
Tramadol promotes the reaction [Ethanol results in increased expression of GJA1 protein] |
CTD |
PMID:33645892 |
|
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
increases expression multiple interactions |
EXP |
Tramadol results in increased expression of GOT1 protein Vitamin E inhibits the reaction [Tramadol results in increased expression of GOT1 protein] |
CTD |
PMID:31618080 |
|
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases activity increases expression multiple interactions |
EXP |
Tramadol results in increased activity of GPT protein Tramadol results in increased expression of GPT protein Vitamin E inhibits the reaction [Tramadol results in increased expression of GPT protein] |
CTD |
PMID:28689766 PMID:31618080 |
|
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
multiple interactions increases expression increases activity |
EXP |
Ketanserin inhibits the reaction [Tramadol results in increased activity of HTR2A protein] Tramadol results in increased expression of HTR2A mRNA |
CTD |
PMID:18417104 |
|
NCBI chr15:56,360,647...56,428,703
Ensembl chr15:49,950,804...50,020,928
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
EXP |
Tramadol promotes the reaction [Ethanol results in increased expression of IFNG protein] |
CTD |
PMID:33645892 |
|
NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ldha |
lactate dehydrogenase A |
decreases expression |
ISO |
Tramadol results in decreased expression of LDHA mRNA |
CTD |
PMID:27317026 |
|
NCBI chr 1:106,508,092...106,517,512
Ensembl chr 1:97,366,021...97,433,472
|
|
G |
Ndufs1 |
NADH:ubiquinone oxidoreductase core subunit S1 |
decreases expression |
ISO |
Tramadol results in decreased expression of NDUFS1 mRNA |
CTD |
PMID:27317026 |
|
NCBI chr 9:72,040,286...72,073,605
Ensembl chr 9:64,546,225...64,579,893
|
|
G |
Oprd1 |
opioid receptor, delta 1 |
affects binding multiple interactions |
EXP |
Tramadol binds to OPRD1 protein [Tramadol binds to OPRD1 protein] which results in decreased uptake of Norepinephrine; [Tramadol binds to OPRD1 protein] which results in decreased uptake of Serotonin |
CTD |
PMID:7562497 |
|
NCBI chr 5:149,590,244...149,624,999
Ensembl chr 5:144,306,188...144,340,960
|
|
G |
Oprk1 |
opioid receptor, kappa 1 |
multiple interactions affects binding |
EXP |
[Tramadol binds to OPRK1 protein] which results in decreased uptake of Norepinephrine; [Tramadol binds to OPRK1 protein] which results in decreased uptake of Serotonin |
CTD |
PMID:7562497 |
|
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:13,860,021...13,877,823
|
|
G |
Oprm1 |
opioid receptor, mu 1 |
multiple interactions affects binding |
EXP |
[Tramadol binds to OPRM1 protein] which results in decreased uptake of Norepinephrine; [Tramadol binds to OPRM1 protein] which results in decreased uptake of Serotonin |
CTD |
PMID:7562497 |
|
NCBI chr 1:45,565,371...45,818,722
Ensembl chr 1:43,160,057...43,413,409
|
|
G |
Pdk3 |
pyruvate dehydrogenase kinase 3 |
increases expression |
ISO |
Tramadol results in increased expression of PDK3 mRNA |
CTD |
PMID:27317026 |
|
NCBI chr X:62,480,535...62,547,371
Ensembl chr X:58,486,554...58,553,557
|
|
G |
Pdyn |
prodynorphin |
decreases expression |
EXP |
Tramadol results in decreased expression of PDYN mRNA |
CTD |
PMID:17401159 |
|
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:116,900,992...116,913,334
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
multiple interactions |
EXP |
[Tiletamine co-treated with Xylazine co-treated with Tramadol] results in increased expression of PRKAA1 mRNA |
CTD |
PMID:31276069 |
|
NCBI chr 2:55,967,766...56,003,450
Ensembl chr 2:54,240,137...54,275,978
|
|
G |
Prkaa2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
multiple interactions |
EXP |
[Tiletamine co-treated with Xylazine co-treated with Tramadol] results in increased expression of PRKAA2 mRNA |
CTD |
PMID:31276069 |
|
NCBI chr 5:125,036,945...125,109,010
Ensembl chr 5:119,813,226...119,879,543
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions |
EXP |
Naloxone inhibits the reaction [Tramadol inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 protein]]; Tramadol inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 mRNA]; Tramadol inhibits the reaction [Streptozocin results in decreased expression of SLC2A4 protein] |
CTD |
PMID:11723065 |
|
NCBI chr10:55,164,721...55,170,289
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Slc47a1 |
solute carrier family 47 member 1 |
multiple interactions |
ISO |
Tramadol inhibits the reaction [SLC47A1 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:22419765 |
|
NCBI chr10:46,533,580...46,590,128
Ensembl chr10:46,034,122...46,087,637
|
|
G |
Slc47a2 |
solute carrier family 47 member 2 |
multiple interactions |
ISO |
Tramadol inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] |
CTD |
PMID:22419765 |
|
NCBI chr10:46,490,262...46,532,954
Ensembl chr10:45,991,095...46,033,904
|
|
G |
Sod1 |
superoxide dismutase 1 |
decreases expression multiple interactions |
EXP |
Tramadol results in decreased expression of SOD1 mRNA; Tramadol results in decreased expression of SOD1 protein Tramadol deficiency inhibits the reaction [Tramadol results in increased expression of SOD1 mRNA] |
CTD |
PMID:25550769 PMID:31618080 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions decreases expression |
EXP |
Tramadol deficiency inhibits the reaction [Tramadol results in increased expression of SOD2 mRNA] Tramadol results in decreased expression of SOD2 mRNA |
CTD |
PMID:25550769 |
|
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
multiple interactions increases expression |
EXP |
Ethanol promotes the reaction [Tramadol results in increased expression of SPP1 protein]; Tramadol promotes the reaction [Ethanol results in increased expression of SPP1 protein] |
CTD |
PMID:33645892 |
|
NCBI chr14:5,613,569...5,620,695
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP |
[Acetaminophen co-treated with Tramadol] inhibits the reaction [Freund's Adjuvant results in increased expression of TNF protein]; Tramadol promotes the reaction [Ethanol results in increased expression of TNF protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of TNF protein] |
CTD |
PMID:17377112 PMID:31618080 PMID:33645892 |
|
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnni3 |
troponin I3, cardiac type |
increases expression multiple interactions |
EXP |
Tramadol results in increased expression of TNNI3 protein Ethanol promotes the reaction [Tramadol results in increased expression of TNNI3 protein]; Tramadol promotes the reaction [Ethanol results in increased expression of TNNI3 protein] |
CTD |
PMID:33645892 |
|
NCBI chr 1:78,342,571...78,346,255
Ensembl chr 1:69,299,900...69,303,580
|
|
G |
Vim |
vimentin |
multiple interactions |
EXP |
Tramadol promotes the reaction [Ethanol results in increased expression of VIM protein] |
CTD |
PMID:33645892 |
|
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
|
|